QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 153 filers reported holding QIAGEN NV in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $534,362,000 | +21.7% | 19,473,847 | -3.3% | 0.53% | +14.1% |
Q2 2016 | $438,999,000 | -4.1% | 20,128,325 | -1.8% | 0.47% | -1.7% |
Q1 2016 | $457,822,000 | -19.4% | 20,493,375 | -0.2% | 0.48% | -18.1% |
Q4 2015 | $567,719,000 | +0.7% | 20,532,325 | -6.1% | 0.58% | -7.3% |
Q3 2015 | $563,908,000 | +0.2% | 21,856,896 | -3.7% | 0.63% | +13.0% |
Q2 2015 | $562,831,000 | -1.7% | 22,703,966 | -0.1% | 0.55% | -0.9% |
Q1 2015 | $572,827,000 | +9.6% | 22,731,216 | +2.0% | 0.56% | +5.5% |
Q4 2014 | $522,784,000 | +4.0% | 22,284,066 | +0.9% | 0.53% | -1.5% |
Q3 2014 | $502,764,000 | -6.9% | 22,080,114 | -0.0% | 0.54% | -9.0% |
Q2 2014 | $540,037,000 | +15.2% | 22,087,404 | -0.7% | 0.59% | +11.3% |
Q1 2014 | $468,926,000 | +1.6% | 22,234,504 | +14.7% | 0.53% | -4.3% |
Q4 2013 | $461,579,000 | +20.6% | 19,385,944 | +8.4% | 0.56% | +10.3% |
Q3 2013 | $382,663,000 | +72.3% | 17,881,461 | +60.3% | 0.50% | +58.2% |
Q2 2013 | $222,054,000 | – | 11,152,875 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |